<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04932486</url>
  </required_header>
  <id_info>
    <org_study_id>B7072020000095</org_study_id>
    <nct_id>NCT04932486</nct_id>
  </id_info>
  <brief_title>Transcutaneous Electrical Stimulation in Obstructive Sleep Apnea</brief_title>
  <official_title>Randomised Controlled Trial of Transcutaneous Electrical Stimulation in Obstructive Sleep Apnea</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Sunrise</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Sunrise</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The aim of this study is to assess the efficacy of transcutaneous electrical stimulation of&#xD;
      the upper airway muscles in patients with obstructive sleep apnea.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">May 26, 2021</start_date>
  <completion_date type="Anticipated">April 2022</completion_date>
  <primary_completion_date type="Anticipated">April 2022</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Participant, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Apnea-hypopnea index (AHI)</measure>
    <time_frame>6 weeks</time_frame>
    <description>Change from baseline to 6 weeks in the apnea-hypopnea index (AHI)</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">60</enrollment>
  <condition>Obstructive Sleep Apnea</condition>
  <arm_group>
    <arm_group_label>Transcutaneous electrical stimulation</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Inactive transcutaneous electrical stimulation</arm_group_label>
    <arm_group_type>Sham Comparator</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Transcutaneous electrical stimulation</intervention_name>
    <description>Transcutaneous electrical stimulation of the upper airway muscles</description>
    <arm_group_label>Transcutaneous electrical stimulation</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Inactive transcutaneous electrical stimulation</intervention_name>
    <description>Inactive transcutaneous electrical stimulation of the upper airway muscles</description>
    <arm_group_label>Inactive transcutaneous electrical stimulation</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion criteria:&#xD;
&#xD;
          -  Obstructive apnea-hypopnea index &gt; 15 events/hour&#xD;
&#xD;
          -  Patients who do not tolerate or do not accept positive airway pressure therapy&#xD;
&#xD;
        Main exclusion criteria:&#xD;
&#xD;
          -  Body mass index &lt; 18.5 or &gt; 32 kg/m2&#xD;
&#xD;
          -  Unable or incapable of providing informed written consent&#xD;
&#xD;
          -  Unwilling or incapable of returning to all follow-up visits and sleep studies,&#xD;
             including evaluation procedures and filling out questionnaires&#xD;
&#xD;
          -  Significant co-morbidities making the patient unable or inappropriate to participate&#xD;
             in the trial&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Jean-Benoit Martinot</last_name>
    <role>Principal Investigator</role>
    <affiliation>Respisom</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Nhat Nam Le Dong</last_name>
    <phone>003281261126</phone>
    <email>nam@hellosunrise.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Respisom</name>
      <address>
        <city>Namur</city>
        <zip>5000</zip>
        <country>Belgium</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jean-Benoit Martinot</last_name>
      <phone>003281310325</phone>
      <email>martinot.j@respisom.be</email>
    </contact>
  </location>
  <location_countries>
    <country>Belgium</country>
  </location_countries>
  <verification_date>June 2021</verification_date>
  <study_first_submitted>June 3, 2021</study_first_submitted>
  <study_first_submitted_qc>June 9, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">June 21, 2021</study_first_posted>
  <last_update_submitted>June 9, 2021</last_update_submitted>
  <last_update_submitted_qc>June 9, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">June 21, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Apnea</mesh_term>
    <mesh_term>Sleep Apnea Syndromes</mesh_term>
    <mesh_term>Sleep Apnea, Obstructive</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

